Ardelyx (FRA:41X) Margin of Safety % (DCF Earnings Based): N/A (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:41X Ardelyx Inc FRA:41X
69 GF Score
Price €3.34
GF Value €7.79
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Ardelyx Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ardelyx's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:41X vs IMTX, TRAX, AVLN: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Ardelyx's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ardelyx Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ardelyx's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Ardelyx's Margin of Safety % (DCF Earnings Based) falls into.


FRA:41X
69GF Score
Ardelyx Inc FRA:41X
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ardelyx (FRA:41X) Overvalued in 2026?

Based on GuruFocus' analysis, Ardelyx stock appears to be undervalued. The current stock price of €3.34 is trading 57.1% below its estimated GF Value™ of €7.79. GuruFocus considers Ardelyx to be Possible Value Trap.

Key valuation signals for FRA:41X:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €7.79 vs. price of €3.34 (57.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the FRA:41X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ardelyx Business Description

Address 400 Fifth Avenue, Suite 210, Waltham, MA, USA, 02451
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
69GF Score

Get the complete analysis for FRA:41X

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.34
Price
€7.79
GF Value